Recombinant Vaccine for Dengue

Vaxinnate Has Received a Grant to Fund The Development of a Recombinant Vaccine
Apr 8, 2013
VaxInnate, a US-based biotechnology firm, has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant vaccine for the prevention of dengue. The grant will provide ...

Tags: Vaxinnate, Recombinant Vaccine for Dengue, Medicine